Abstract:Mesenchymal stem cells (MSCs) can act as a carrier in tumor therapy, and tumor suppressor gene-modified MSCs can reach and suppress the tumor. However, in the colon cancer microenvironment, MSCs could promote tumor growth and create the environment that is conducive to the survival of cancer stem cells (CSCs). This study discovered MSCs from three sources (bone marrow, adipose, placenta) could induce the stemness and epithelial–mesenchymal transition (EMT) of HCT116 in vitro, meanwhile adipose- and placenta-derived MSCs increase the proportion of CD133+/CD44+ HCT116. Then, we explored the interaction mechanism between CD133+/CD44+ HCT116 and MSCs by the bioinformatics and in vitro assays. After CD133+/CD44+ HCT116 were co-cultured with MSCs, many cytokines in MSCs were stimulated, including interleukin-8 (IL-8). The binding of IL-8/CXCR2 activates the downstream mitogen-activated protein kinase (MAPK) signaling pathway in colon CSCs, thereby promoting the stemness and EMT. However, inhibition of IL-8/CXCR2/Erk1/2 could reverse the effect of MSCs on CSC stemness. In addition, MSCs co-cultured with CD133+/CD44+ HCT116 produce a carcinoma-associated fibroblast phenotype via intracellular FGF10–PKA–Akt–β-catenin signaling, which can be attenuated by IL-8 peptide inhibitor. To conclude, IL-8 promotes the interaction between colon CSCs and MSCs, and activates the MAPK signaling pathway in colon CSCs, which provides a theoretical basis for the application of MSCs in clinical practice. Impact statement MSCs have the property of chemotaxis and they can migrate to the tumor site by paracrine pathway in the tumor environment, and then interact with tumor cells. Although a mass of studies have been conducted about the impact of MSCs on tumors, it is still controversial whether the exogenous MSCs promote or inhibit tumor growth. In this work, we evaluated the effects of MSCs from three sources (bone marrow, adipose, placenta) on the proliferation, stemness, and metastasis of the colon cancer cells both in vitro and in vivo. Then, we proved the IL-8/CXCR2/MAPK and FGF10–PKA–Akt–β-catenin signaling pathway which mediate the interplay between MSC and CD133+/CD44+ colon cancer cell. This research aims to provide a theoretical basis for the safe application of MSCs in the clinical treatment of colon cancer.

Protein Arginine Methyltransferase 8 Gene Enhances the Colon Cancer Stem Cell (CSC) Function by Upregulating the Pluripotency Transcription Factor

Endothelial Cells Activate the Cancer Stem Cell-Associated Nanogp8 Pathway in Colorectal Cancer Cells in A Paracrine Fashion

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Phosphodiesterase 5/protein Kinase G Signal Governs Stemness of Prostate Cancer Stem Cells Through Hippo Pathway.

FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function

PRMT5 Determines the Sensitivity to Chemotherapeutics by Governing Stemness in Breast Cancer

Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity

PRMT1 Regulates the Tumour-Initiating Properties of Esophageal Squamous Cell Carcinoma Through Histone H4 Arginine Methylation Coupled with Transcriptional Activation

PRMT6 functionally associates with PRMT5 to promote colorectal cancer progression through epigenetically repressing the expression of CDKN2B and CCNG1

PP4R1 Induced Cancer Stemness by Upregulating the Expression of OCT4 Via the MAPK/ERK Pathway in NSCLC

Abstract 4479: Protein Arginine Methyltransferase PRMT6 Regulates Cancer Stemness Through CRAF Methylation in Hepatocellular Carcinoma

TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling

LncRNA KLK8 modulates stem cell characteristics in colon cancer

Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c‐Myc‐mediated BCAT1 downregulation

Feature Article: Mesenchymal Stem Cells Maintain the Stemness of Colon Cancer Stem Cells Via Interleukin-8/Mitogen-activated Protein Kinase Signaling Pathway

Pluripotency transcription factors and cancer stem cells: small genes make a big difference

Coordinated Regulation of the Ribosome and Proteasome by PRMT1 in the Maintenance of Neural Stemness in Cancer Cells and Neural Stem Cells

PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling

Sox8 Regulates Cancer Stem-Like Properties And Cisplatin-Induced Emt In Tongue Squamous Cell Carcinoma By Acting On The Wnt/Beta-Catenin Pathway

Overexpression of Protein Regulator of Cytokinesis 1 Facilitates Tumor Growth and Indicates Unfavorable Prognosis of Patients with Colon Cancer

Induced Pluripotent Stem Cell-Related Genes Influence Biological Behavior and 5-Fluorouracil Sensitivity of Colorectal Cancer Cells